Integrative omics analyses broaden treatment targets in human cancer

BACKGROUND: Although large-scale, next-generation sequencing (NGS) studies of cancers hold promise for enabling precision oncology, challenges remain in integrating NGS with clinically validated biomarkers. METHODS: To overcome such challenges, we utilized the Database of Evidence for Precision Onco...

Descripción completa

Detalles Bibliográficos
Autores principales: Sengupta, Sohini, Sun, Sam Q., Huang, Kuan-lin, Oh, Clara, Bailey, Matthew H., Varghese, Rajees, Wyczalkowski, Matthew A., Ning, Jie, Tripathi, Piyush, McMichael, Joshua F., Johnson, Kimberly J., Kandoth, Cyriac, Welch, John, Ma, Cynthia, Wendl, Michael C., Payne, Samuel H., Fenyö, David, Townsend, Reid R., Dipersio, John F., Chen, Feng, Ding, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6064051/
https://www.ncbi.nlm.nih.gov/pubmed/30053901
http://dx.doi.org/10.1186/s13073-018-0564-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6064051/
https://www.ncbi.nlm.nih.gov/pubmed/30053901
http://dx.doi.org/10.1186/s13073-018-0564-z

Ejemplares similares